Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Headache-inducing effects of cilostazol in migraine without aura
2025-521520-29-00Phase 2Completed
- Sponsor
- University of Southern Denmark
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cilostazol in migraine without aura (2 arms), sponsored by University of Southern Denmark. Primary endpoints: Migraine-like attacks incidence: cilostazol vs placebo in men and Migraine-like attacks incidence: cilostazol in men vs women. Started Jun 2025; status: completed.
02
Drugs
cilostazol
03
Conditions
migraine without aura
Beyond the preview
Go deeper on 2025-521520-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521520-29-00.